AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups

AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to...